131 related articles for article (PubMed ID: 23402453)
1. The costs associated with sleep symptoms among patients with fibromyalgia.
Wagner JS; Chandran A; DiBonaventura M; Cappelleri JC
Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):131-9. PubMed ID: 23402453
[TBL] [Abstract][Full Text] [Related]
2. Impact of fibromyalgia severity on health economic costs: results from a European cross-sectional study.
Winkelmann A; Perrot S; Schaefer C; Ryan K; Chandran A; Sadosky A; Zlateva G
Appl Health Econ Health Policy; 2011 Mar; 9(2):125-36. PubMed ID: 21332254
[TBL] [Abstract][Full Text] [Related]
3. The burden of diurnal and nocturnal gastroesophageal reflux disease symptoms.
Wagner JS; DiBonaventura MD; Balu S; Buchner D
Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):739-49. PubMed ID: 22098290
[TBL] [Abstract][Full Text] [Related]
4. The Comparative Burden of Chronic Widespread Pain and Fibromyalgia in the United States.
Schaefer C; Mann R; Masters ET; Cappelleri JC; Daniel SR; Zlateva G; McElroy HJ; Chandran AB; Adams EH; Assaf AR; McNett M; Mease P; Silverman S; Staud R
Pain Pract; 2016 Jun; 16(5):565-79. PubMed ID: 25980433
[TBL] [Abstract][Full Text] [Related]
5. Economic cost and epidemiological characteristics of patients with fibromyalgia claims.
Robinson RL; Birnbaum HG; Morley MA; Sisitsky T; Greenberg PE; Claxton AJ
J Rheumatol; 2003 Jun; 30(6):1318-25. PubMed ID: 12784409
[TBL] [Abstract][Full Text] [Related]
6. The impact of 'best-practice' patient care in fibromyalgia on practice economics.
Brown TM; Garg S; Chandran AB; McNett M; Silverman SL; Hadker N
J Eval Clin Pract; 2012 Aug; 18(4):793-8. PubMed ID: 21539697
[TBL] [Abstract][Full Text] [Related]
7. Comparison of health care use and costs in newly diagnosed and established patients with fibromyalgia.
White LA; Robinson RL; Yu AP; Kaltenboeck A; Samuels S; Mallett D; Birnbaum HG
J Pain; 2009 Sep; 10(9):976-83. PubMed ID: 19556168
[TBL] [Abstract][Full Text] [Related]
8. Treatment patterns among physician specialties in the management of fibromyalgia: results of a cross-sectional study in the United States.
McNett M; Goldenberg D; Schaefer C; Hufstader M; Baik R; Chandran A; Zlateva G
Curr Med Res Opin; 2011 Mar; 27(3):673-83. PubMed ID: 21294700
[TBL] [Abstract][Full Text] [Related]
9. Prospective study of the use of healthcare resources and economic costs in patients with fibromyalgia after treatment in routine medical practice.
Rivera J; Rejas-Gutiérrez J; Vallejo MA; Esteve-Vives J; De Salas-Cansado M;
Clin Exp Rheumatol; 2012; 30(6 Suppl 74):31-8. PubMed ID: 22935246
[TBL] [Abstract][Full Text] [Related]
10. Resource utilisation and health care costs in patients diagnosed with fibromyalgia in Spain.
Rivera J; Rejas J; Esteve-Vives J; Vallejo MA;
Clin Exp Rheumatol; 2009; 27(5 Suppl 56):S39-45. PubMed ID: 20074438
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
Pelletier EM; Shim B; Goodman S; Amonkar MM
Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of patients with fibromyalgia in France and Germany.
Perrot S; Winkelmann A; Dukes E; Xu X; Schaefer C; Ryan K; Chandran A; Sadosky A; Zlateva G
Int J Clin Pract; 2010 Jul; 64(8):1100-8. PubMed ID: 20497264
[TBL] [Abstract][Full Text] [Related]
13. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
Phanthunane P; Whiteford H; Vos T; Bertram M
J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal evaluation of health care utilization and costs during the first three years after a new diagnosis of fibromyalgia.
Sanchez RJ; Uribe C; Li H; Alvir J; Deminski M; Chandran A; Palacio A
Curr Med Res Opin; 2011 Mar; 27(3):663-71. PubMed ID: 21241205
[TBL] [Abstract][Full Text] [Related]
15. Estimating the economic benefits of positive shifts in fibromyalgia severity: an exploratory analysis based on modeling of clinical trial data of pregabalin.
Cappelleri JC; Bushmakin AG; Zlateva G; Chandran A
J Med Econ; 2013; 16(1):55-61. PubMed ID: 22954060
[TBL] [Abstract][Full Text] [Related]
16. Health services costs and their determinants in women with fibromyalgia.
Penrod JR; Bernatsky S; Adam V; Baron M; Dayan N; Dobkin PL
J Rheumatol; 2004 Jul; 31(7):1391-8. PubMed ID: 15229962
[TBL] [Abstract][Full Text] [Related]
17. The London Fibromyalgia Epidemiology Study: direct health care costs of fibromyalgia syndrome in London, Canada.
White KP; Speechley M; Harth M; Ostbye T
J Rheumatol; 1999 Apr; 26(4):885-9. PubMed ID: 10229411
[TBL] [Abstract][Full Text] [Related]
18. Healthcare utilization and expenditures in patients with atrial fibrillation treated with catheter ablation.
Ladapo JA; David G; Gunnarsson CL; Hao SC; White SA; March JL; Reynolds MR
J Cardiovasc Electrophysiol; 2012 Jan; 23(1):1-8. PubMed ID: 21777324
[TBL] [Abstract][Full Text] [Related]
19. Payer costs in patients undergoing uterine artery embolization, hysterectomy, or myomectomy for treatment of uterine fibroids.
Dembek CJ; Pelletier EM; Isaacson KB; Spies JB
J Vasc Interv Radiol; 2007 Oct; 18(10):1207-13. PubMed ID: 17911509
[TBL] [Abstract][Full Text] [Related]
20. Burden of fibromyalgia and comparisons with osteoarthritis in the workforce.
Kleinman N; Harnett J; Melkonian A; Lynch W; Kaplan-Machlis B; Silverman SL
J Occup Environ Med; 2009 Dec; 51(12):1384-93. PubMed ID: 19952796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
